Supernus Pharmaceuticals
SUPN
#4517
Rank
S$2.30 B
Marketcap
$41.85
Share price
0.91%
Change (1 day)
8.20%
Change (1 year)

Supernus Pharmaceuticals (SUPN) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : S$0.46 B

According to Supernus Pharmaceuticals 's latest financial reports the company's total liabilities are S$0.46 B. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Supernus Pharmaceuticals - Total liabilities on balance sheet (from 2009 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31S$0.47 B-57.02%
2022-12-31S$1.09 B-7.08%
2021-12-31S$1.17 B17.33%
2020-12-31S$1.00 B32.15%
2019-12-31S$0.75 B6.25%
2018-12-31S$0.71 B240.48%
2017-12-31S$0.20 B23.14%
2016-12-31S$0.17 B19.69%
2015-12-31S$0.14 B12.21%
2014-12-31S$0.12 B29.22%
2013-12-31S$98.24 M120.45%
2012-12-31S$44.56 M-22.3%
2011-12-31S$57.35 M-51.27%
2010-12-31S$0.11 B-2.68%
2009-12-31S$0.12 B0.26%
2008-12-31S$0.12 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
S$1.33 B 186.29%๐Ÿ‡บ๐Ÿ‡ธ USA
S$75.85 B 16,150.94%๐Ÿ‡บ๐Ÿ‡ธ USA
S$101.04 B 21,546.88%๐Ÿ‡บ๐Ÿ‡ธ USA
S$43.57 B 9,235.75%๐Ÿ‡บ๐Ÿ‡ธ USA
S$142.69 B 30,468.54%๐Ÿ‡บ๐Ÿ‡ธ USA